Compare Ishares Msci Spain ETF (EWP) vs GSK plc (GSK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ishares Msci Spain ETF vs GSK plc — how do they compare? Ishares Msci Spain ETF trades at $62.71, while GSK plc trades at $50.56 (market cap $102.60B). The key difference: GSK plc pays a 3.57% dividend while Ishares Msci Spain ETF pays none, and Ishares Msci Spain ETF is trading nearer its 52-week high, GSK plc nearer its low. Which is the better fit depends on your goals.
| EWP | GSK | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $62.66 | $61.18 |
52-Week Low | $47.02 | $38.22 |
Market Cap | — | $102.60B |
Enterprise Value | — | $123.04B |
Dividend Yield | — | 3.57% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWP shares trade at $62.80, up 0.62% with a bullish technical bias from moving averages but overbought RSI signals. The stock shows strong institutional support with 17 buy signals versus 7 sells. Recent dividend declaration of $0.92 per share for H1-2026 indicates management's confidence in cash flow stability. European market exposure provides diversification benefits amid U.S. market volatility.
Outlook remains cautiously optimistic given technical strength and dividend commitment, though valuation metrics are unavailable for fundamental assessment. Key risks include European economic sensitivity and currency fluctuations. The stock's proximity to resistance at $63 requires monitoring for breakout confirmation or pullback opportunities.
GSK trades at $50.27, down 3.62% today, with a bearish technical signal but strong fundamentals including a P/E of 16.02 and net income margin of 14.52%. Recent quarters show earnings beats, and the company announced a $2.52 billion cost-saving plan to boost its drug pipeline. Cash flow from operations remains robust at $7.74 billion for 2025.
The outlook is mixed: analyst consensus leans hold (55.18%) amid valuation concerns, but revenue growth and pipeline investments support long-term potential. Key risks include competitive pressures and regulatory uncertainty, as highlighted by recent news on vaccine policies. The stock offers a dividend yield with payments scheduled through 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ishares Msci Spain ETF
EWP is a country-specific ETF that tracks the performance of the Spanish equity market. It provides targeted access to large and mid-sized companies in Spain, with heavy weightings in financials and utilities like Banco Santander and Iberdrola.
Read more on EWP →About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →
